Mucosal Atrophy and Intestinal Metaplasia

Slide 1 · Mucosal Atrophy and

Intestinal Metaplasia

Gastric mucosal injury, remodeling, and neoplastic risk

Chronic gastritis · oxyntic gland loss · intestinal differentiation · dysplasia

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Define mucosal atrophy, intestinal metaplasia, and epithelial dysplasia without conflating them.

Connect H. Pylori and autoimmune gastritis to characteristic distributions of gland loss.

Recognize the morphologic basis of intestinal metaplasia and dysplasia.

Explain why chronic atrophy and metaplasia matter for gastric neoplasia.

Slide 3 · Three distinct epithelial abnormalities

Process

Defining change

Diagnostic implication

Atrophy

Loss of normal gastric glands

Assess location and residual gland types

Metaplasia

Intestinal differentiation within gastric mucosa

Look for goblet cells

Dysplasia

Preinvasive cytologic and architectural atypia

Distinguish from reactive repair

Slide 4 · Normal gastric regions are not interchangeable

Body and fundus

Oxyntic glands contain acid-secreting parietal cells.

Chief cells provide digestive zymogens.

Major site of autoimmune-mediated gland loss.

Antrum

Predominantly mucus-producing pyloric glands.

G cells regulate gastrin secretion.

Frequent initial focus of H. Pylori gastritis.

Slide 5 · Oxyntic mucosa: The relevant glandular compartment

Schematic: Not a histologic specimen

Recognize the normal compartment

Surface foveolae open into deeper gastric glands.

Parietal and chief cells account for characteristic oxyntic differentiation.

Loss of these glands is central to corpus atrophy.

Slide 6 · The core lesion begins with chronic gastric injury

Persistent mucosal inflammation

Loss of specialized glands

Mucosal remodeling

Metaplasia may emerge

The morphologic outcome depends on cause, regional distribution, and persistence of injury.

Slide 7 · Atrophy and metaplasia: Related, not synonymous

Mucosal atrophy

Defined by loss of native glands.

May lower secretory capacity in oxyntic mucosa.

Can coexist with metaplastic epithelium.

Intestinal metaplasia

Defined by intestinal-type differentiation.

Identified morphologically by goblet cells.

Can occur in an atrophic inflammatory background.

Slide 8 · Two major pathways to atrophic gastritis

H. Pylori infection

Chronic gastritis

Oxyntic gland depletion

Atrophy ± metaplasia

Autoimmune-mediated body/fundus injury is a separate initiating pathway; Do not assign both causes automatically.

Slide 9 · H. Pylori persists within the gastric mucus niche

Motility in mucus

Urease-mediated buffering

Adherence to foveolar cells

Sustained inflammation

Flagella, urease and adhesins support persistence; Host and bacterial factors modify disease.

Slide 10 · Antral-predominant H. Pylori gastritis

Typical earlier pattern

Predominant antral inflammation.

Organisms in superficial mucus and foveolar region.

Plasma cells, lymphocytes and neutrophils.

Functional tendency

Gastrin production may increase locally.

Acid secretion remains normal or rises.

Peptic ulcer tendency differs from atrophic disease.

Slide 11 · Progression can extend into body and fundus

Antral infection

Prolonged chronic gastritis

Corpus/fundus involvement

Patchy oxyntic atrophy

The progression is possible, not obligatory: H. Pylori infection has heterogeneous outcomes.

Slide 12 · Patchiness is a diagnostic feature in H. Pylori atrophy

Topographic pattern

Atrophic foci may be discontinuous.

Residual oxyntic glands may persist nearby.

Colonization and inflammation may be irregular.

Interpretation

A small biopsy samples only part of the mucosa.

Antrum and corpus must not be treated as interchangeable.

Patchy injury contrasts with typical autoimmune distribution.

Slide 13 · Host and bacterial determinants modify progression

Bacterial virulence factors

Host inflammatory response

Glandular injury

Variable atrophic outcome

CagA-associated strains and host cytokine responses are discussed by Robbins as modifiers, not deterministic tests.

Slide 14 · Autoimmune gastritis targets the oxyntic compartment

Immune recognition of parietal-cell antigens

Deep gland-centered injury

Parietal/chief cell loss

Diffuse body/fundus atrophy

Autoantibodies to H⁺/K⁺-ATPase and intrinsic factor support the autoimmune phenotype.

Slide 15 · Autoimmune distribution: Body predominant, antrum spared

BODY / FUNDUS

ANTRUM

Primary injury in autoimmune pattern

Often spared

Schematic regional map, not anatomical scale

Body and fundus: Principal site of glandular damage.

Antrum: Typically relatively spared.

Topography helps separate autoimmune from H. Pylori-associated injury.

Slide 16 · Oxyntic destruction reduces acid production

Parietal-cell depletion

Reduced acid secretion

Low luminal acidity

Compensatory gastrin release

Autoimmune destruction can lead to achlorhydria and marked hypergastrinemia.

Slide 17 · Cause and location predict acid physiology

Phenotype

Gland preservation

Acid pattern

Antral-predominant H. pylori

Oxyntic glands relatively preserved

Normal or increased

Atrophic H. pylori

Patchy oxyntic loss

Reduced

Autoimmune body gastritis

Extensive oxyntic loss

Markedly reduced / absent

Slide 18 · Parietal cells link gastric injury to vitamin B₁₂ status

Parietal-cell loss

Intrinsic-factor deficiency

Defective ileal B₁₂ absorption

Pernicious anemia may develop

Vitamin B₁₂ deficiency is a downstream clinical effect of autoimmune atrophic gastritis.

Slide 19 · Achlorhydria alters gastric feedback

Oxyntic atrophy

Loss of gastric acidity

Feedback-driven gastrin secretion

Antral G-cell stimulation

Marked hypergastrinemia is characteristic of autoimmune atrophic gastritis.

Slide 20 · Enterochromaffin-like cell hyperplasia can accompany atrophy

Achlorhydria

Persistent hypergastrinemia

ECL-cell proliferation

Occasional low-grade NET

Small multicentric gastric-body neuroendocrine tumors as an uncommon downstream event.

Slide 21 · Atrophic oxyntic mucosa may become visibly thin

Normal oxyntic mucosa

Preserved body/fundus gland population.

Rugal architecture maintained.

Acid-producing compartment intact.

Advanced autoimmune atrophy

Marked mucosal thinning.

Loss of rugal folds.

Residual gland islands may appear as nodules.

Slide 22 · Mucosal atrophy means loss of original glands

Schematic: Not a histologic specimen

Read the gland count

Compare gland density and recognizable cell populations.

Atrophic mucosa has fewer specialized oxyntic glands.

Do not diagnose atrophy by inflammation alone.

Slide 23 · The cellular signature is parietal and chief cell depletion

Schematic: Not a histologic specimen

Read the cellular loss

Parietal cells are the acid- and intrinsic-factor-producing lineage.

Chief cells are another component of oxyntic glands.

Conspicuous loss of both supports oxyntic glandular atrophy.

Slide 24 · Intestinal metaplasia is epithelial lineage replacement

Chronically injured gastric mucosa

Adaptive epithelial remodeling

Intestinal-type differentiation

Goblet cells appear

The appearance of intestinal-type cells defines metaplasia; It is not invasive carcinoma.

Slide 25 · Goblet cells establish intestinal differentiation

Schematic — simplified epithelial cells

Goblet-cell morphology

Pale cytoplasmic mucin displaces the nucleus toward the base.

Goblet cells are identifiable in gastric epithelium.

Their presence is the key microscopic recognition point.

Slide 26 · Intestinal-type epithelium may include absorptive cells

Schematic — simplified epithelial cells

Intestinal-type lineages

Metaplastic mucosa can contain absorptive-type columnar cells.

Goblet cells remain the most practical recognition feature.

Different intestinal-type lineages may coexist in one focus.

Slide 27 · Paneth cells may accompany gastric intestinal metaplasia

Schematic — simplified epithelial cells

Paneth-cell variation

Paneth cells are present in some intestinalized gastric glands.

They are not required for a diagnosis of intestinal metaplasia.

Their presence reinforces intestinal differentiation.

Slide 28 · Gastric-to-intestinal shift is a differentiation change

Schematic: Not a histologic specimen

Read the cell lineage

Normal gastric mucosa contains native gastric glandular lineages.

Metaplastic foci contain intestinal-type elements.

The process is a tissue response associated with chronic injury.

Slide 29 · Atrophy and metaplasia often coexist in one biopsy

Atrophic background

Depletion of native oxyntic glands.

Chronic inflammatory background may remain.

Altered endocrine and secretory physiology.

Metaplastic focus

Goblet cells within gastric epithelium.

Possible absorptive or Paneth differentiation.

A separate morphologic observation from atrophy.

Slide 30 · Regional context prevents misinterpretation

Biopsy location

Relevant native mucosa

Key concern

Body / fundus

Parietal- and chief-cell-rich oxyntic glands

Oxyntic gland depletion

Antrum

Pyloric-type glands

Chronic inflammation and metaplasia

Mixed / unknown site

Variable mucosal phenotypes

Avoid ungrounded etiologic assignment

Slide 31 · Histology reading sequence: Identity before inference

Identify mucosal region

Assess native glands

Look for goblet cells

Evaluate atypia

Only then integrate inflammatory pattern and clinical context to infer likely cause.

Slide 32 · Inflammatory distribution supports the etiologic distinction

Feature

H. pylori gastritis

Autoimmune gastritis

Preferred site

Antrum; may extend to body

Body / fundus

Inflammatory emphasis

Superficial lamina propria

Deep, gland-centered

Neutrophils

Often prominent

Usually not prominent

Oxyntic loss

Typically patchy if present

Often diffuse

Slide 33 · Endoscopic appearance is not a microscopic diagnosis

What endoscopy can suggest

Thin gastric folds / mucosa.

Nodularity or small elevations.

Heterogeneous geographic changes.

What biopsy establishes

Loss of specific gland types.

Goblet cells in gastric epithelium.

Reactive versus dysplastic epithelial maturation.

Slide 34 · A case of patchy body atrophy

A body biopsy shows focal parietal-cell depletion and intestinalized epithelium; Adjacent areas retain oxyntic glands.

Consider an atrophic gastritis pattern with patchy remodeling.

Patchiness is compatible with H. Pylori-associated injury.

Diagnosis still requires assessment of inflammation and organism status.

Goblet cells establish the metaplastic component.

Slide 35 · A case of diffuse corpus-predominant atrophy

Gastric body mucosa is markedly thin, with deep gland-centered inflammation, loss of specialized cells, and relative antral sparing.

An autoimmune pattern is favored.

Topographic restriction points toward corpus-directed injury.

Reduced acid and intrinsic-factor production are mechanistically plausible.

Correlate with the autoimmune serologic and clinical phenotype.

Slide 36 · Why the lesion matters beyond inflammation

Chronic injury

Oxyntic gland loss

Intestinal metaplasia

Elevated adenocarcinoma risk

The sequence represents an association with risk; Metaplasia is not synonymous with carcinoma.

Slide 37 · Achlorhydria and nitrosamines: A proposed mechanism

Atrophic loss of acid secretion

More permissive bacterial growth

Carcinogenic nitrosamine generation

Possible oncogenic contribution

This as a possible explanation; It is not a proven single-cause pathway.

Slide 38 · Cancer risk is a clinicopathologic association

Supported by source

Atrophy with intestinal metaplasia is linked to increased gastric adenocarcinoma risk.

The text highlights autoimmune metaplastic atrophic gastritis.

Chronic injury can precede dysplasia.

Not justified by the lesion alone

No individual absolute risk can be assigned from this excerpt.

No inference that every metaplastic focus will progress.

No molecular or staging threshold is supplied.

Slide 39 · Persistent inflammation can produce genetic damage

Chronic inflammatory mediators

Free-radical injury

Regenerative proliferation

Accumulated genetic alterations

The dysplasia section links oxidative injury and repeated growth signals to epithelial evolution.

Slide 40 · Gastrin can be part of a proliferative milieu

Gastric gland injury

Altered acid feedback

Increased gastrin

Epithelial proliferative drive

Gastrin as a gastric epithelial mitogen alongside inflammation-related stimuli.

Slide 41 · Dysplasia is a preinvasive epithelial lesion

Metaplasia

Intestinal-type differentiation.

Goblet cells may be conspicuous.

Does not itself establish cytologic malignancy.

Dysplasia

Altered epithelial size, shape and orientation.

Nuclear atypia with disordered maturation.

Considered a preinvasive in situ lesion.

Slide 42 · Dysplastic nuclear morphology has specific features

Nuclear enlargement with hyperchromasia.

Coarse chromatin texture.

Variability in epithelial nuclear size and shape.

Distorted nuclear orientation relative to epithelial architecture.

Slide 43 · Architecture and polarity contribute to dysplasia

Reactive repair

Surface cells mature

Dysplastic epithelium

Atypia persists to surface

Persistent abnormal cellular orientation strengthens concern for dysplasia.

Slide 44 · Regenerative atypia is a central diagnostic pitfall

Reactive change

Occurs with active injury and regeneration.

Can feature proliferative expansion and mitoses.

Surface cells tend to mature.

Potential dysplasia

Atypia exceeds expected reparative changes.

Disordered size, shape and orientation.

Cytologic immaturity can persist at the surface.

Slide 45 · Surface maturation helps resolve the pitfall

Examine gland base

Trace epithelium upward

Evaluate surface maturation

Interpret reactive versus dysplastic

A retained surface maturation gradient favors regeneration; Persistent immaturity favors dysplasia.

Slide 46 · Reactive versus dysplastic epithelium

Microscopic feature

Regenerative change

Dysplasia

Mitoses / proliferation

May be increased

May be increased

Nuclear atypia

May be present

Usually persistent and disordered

Surface differentiation

Maturation retained

Immaturity persists

Interpretive approach

Injury context is essential

Integrate nuclear and architectural changes

Slide 47 · Interpretation requires multiple morphologic clues

Background inflammation

Architectural pattern

Nuclear abnormalities

Surface maturation

Do not treat a single mitotic figure or an enlarged nucleus as a definitive diagnosis.

Slide 48 · A common overcall: Regeneration mistaken for dysplasia

An inflamed gastric biopsy shows prominent regenerative mitoses at gland bases, but the surface epithelium becomes orderly and cytologically mature.

The maturation pattern supports reactive/regenerative atypia.

Active inflammation can drive vigorous proliferation.

Mitotic activity alone cannot define dysplasia.

Surface maturation is the source-provided discriminator.

Slide 49 · A concerning pattern: Atypia persists to the surface

A gastric biopsy shows coarse nuclear chromatin, enlarged hyperchromatic nuclei, disordered orientation, and no clear surface maturation.

The combination supports concern for dysplasia.

Atypia spans the gland-to-surface axis.

Structural and nuclear abnormalities reinforce one another.

The interpretation is morphologic, not based only on mitotic count.

Slide 50 · H. Pylori eradication may permit metaplastic regression

Persistent infection

Eradication treatment

Inflammatory stimulus reduced

Metaplasia may regress

“May regress” is the source wording; Restoration is neither uniform nor assured.

Slide 51 · Treatment response does not erase prior morphology

After eradication: Possible

Reduced active infectious inflammation.

Clinical improvement in H. Pylori gastritis.

Regression of some metaplastic change.

Not guaranteed

Immediate restoration of lost glands.

Reversal of all metaplastic foci.

Elimination of all neoplastic risk from prior injury.

Slide 52 · Avoid deterministic causal statements

Claim

Responsible interpretation

Atrophy → carcinoma in every case

Association with elevated risk, not inevitability

Metaplasia proves current H. pylori

Multiple etiologic pathways exist

Autoantibody positivity alone proves gland loss

Correlation with topography and tissue morphology

Eradication always reverses metaplasia

Regression may occur; not guaranteed

Slide 53 · Autoimmune atrophy: Clinical consequences

Parietal-cell loss

Achlorhydria + intrinsic-factor loss

Hypergastrinemia + B₁₂ deficiency

Endocrine and hematologic effects

The glandular lesion unifies the gastric and extra-gastric phenotype.

Slide 54 · Vitamin B₁₂ deficiency can have systemic manifestations

Megaloblastic anemia and related hematologic effects.

Atrophic glossitis with a smooth, erythematous tongue.

Malabsorptive symptoms may develop.

Neurologic injury can accompany severe or longstanding deficiency.

Slide 55 · Endocrine changes are distinct from adenocarcinoma risk

ECL-cell pathway

Hypergastrinemia drives endocrine-cell hyperplasia.

Occasional gastric-body low-grade neuroendocrine tumors.

A consequence highlighted in autoimmune gastritis.

Epithelial adenocarcinoma association

Chronic atrophy and metaplasia are risk-associated lesions.

Inflammation and epithelial damage may culminate in dysplasia.

A different neoplastic lineage and pathobiology.

Slide 56 · Gastritis cystica is an important reactive mimic

Prior injury / surgery association

Reactive epithelial proliferation

Entrapped epithelial cysts in wall

Mimic of invasive carcinoma

The cause of deep cyst formation is not fully established.

Slide 57 · Entrapped glands are not automatically invasive cancer

Gastritis cystica

Epithelium-lined cysts may lie beneath mucosa.

Cystica polyposia: Submucosal level.

Cystica profunda: Deeper gastric wall.

Diagnostic caution

Prominent reactive atypia may be present.

Depth alone is an insufficient cancer diagnosis.

Avoid mistaking reactive entrapment for invasive carcinoma.

Slide 58 · Hypertrophic gastropathy is a different growth pattern

Atrophic remodeling

Loss of gastric glands.

Potential thinning of corpus mucosa.

Chronic inflammatory etiologies.

Hypertrophic gastropathy

Enlarged cerebriform gastric folds.

Epithelial hyperplasia rather than gland loss.

Defined without inflammatory change in the source.

Slide 59 · A focused gastric biopsy description

State gastric region where known and whether the native glands are preserved.

Describe glandular loss separately from intestinal metaplasia.

Identify characteristic inflammation and reactive versus dysplastic changes.

Use etiologic language only when adequately supported by morphology and context.

Slide 60 · Integrated comparison of the principal patterns

Feature

H. pylori-associated atrophy

Autoimmune atrophy

Distribution

Often patchy; may involve corpus

Body/fundus predominant

Antibodies

Not characteristic

Parietal-cell / intrinsic-factor

Acid secretion

May decline with oxyntic injury

Often markedly reduced

Other effects

Metaplasia; carcinoma association

B₁₂ deficiency; ECL hyperplasia

Slide 61 · Clinicopathologic exercise: Three biopsy statements

A: Goblet cells are present. B: Oxyntic glands are depleted. C: Hyperchromatic nuclei remain immature at the surface.

Three observations represent three different diagnoses.

A identifies intestinal metaplasia.

B establishes oxyntic glandular atrophy.

C supports a dysplastic epithelial pattern.

Slide 62 · Final synthesis: Read gland, lineage, and maturation

Gland loss?

Intestinal lineage?

Surface dysmaturation?

Integrate cause and risk

Atrophy, metaplasia and dysplasia have separate morphologic meanings.

Slide 63 · Source and scope

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026).

Core discussion: gastric mucosal atrophy, intestinal metaplasia and dysplasia.

Supporting sections: H. pylori gastritis, autoimmune gastritis and gastritis cystica.

All epithelial/glandular illustrations are original editable conceptual schematics, not histopathology specimens.